rac-1-((9H-carbazol-4-yl)oxy)-3-(4-(pyridin-2-yl)piperazin-1-yl)propan-2-ol

ID: ALA4638494

PubChem CID: 156012384

Max Phase: Preclinical

Molecular Formula: C24H26N4O2

Molecular Weight: 402.50

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  OC(COc1cccc2[nH]c3ccccc3c12)CN1CCN(c2ccccn2)CC1

Standard InChI:  InChI=1S/C24H26N4O2/c29-18(16-27-12-14-28(15-13-27)23-10-3-4-11-25-23)17-30-22-9-5-8-21-24(22)19-6-1-2-7-20(19)26-21/h1-11,18,26,29H,12-17H2

Standard InChI Key:  UNLURZYRMFQZBM-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 30 34  0  0  0  0  0  0  0  0999 V2000
   28.4547  -27.2964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4547  -26.4714    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.3214  -26.4588    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.8839  -26.4714    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.1672  -26.0588    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.6048  -26.0588    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8964  -27.2964    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.1714  -28.5339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.1714  -27.7089    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4589  -28.9464    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.7418  -28.5339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.7463  -27.7089    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.9557  -28.7845    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.4744  -28.1143    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.9647  -27.4518    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6360  -26.6980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.8171  -26.6056    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3282  -27.2731    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.6597  -28.0242    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.3334  -27.2838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.0299  -26.0360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.7502  -26.4380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.7622  -27.2630    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.0538  -27.6859    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.4826  -27.6651    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.4931  -28.4891    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.2127  -28.8911    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.9221  -28.4682    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.9075  -27.6390    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.1873  -27.2407    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 12  1  0
  2  1  1  0
  3  6  1  0
  4  5  1  0
  5  2  1  0
  6  4  1  0
  7  4  1  0
  8 10  2  0
  9  1  2  0
 10 11  1  0
  9  8  1  0
 11 12  2  0
 12 15  1  0
 14 13  1  0
 13 11  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
  3 20  1  0
  3 21  1  0
 21 22  1  0
 20 24  1  0
 22 23  1  0
 23 24  1  0
 23 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 25  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4638494

    ---

Associated Targets(Human)

SK-MEL-5 (47095 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-MEL-28 (48833 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A-375 (9258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 402.50Molecular Weight (Monoisotopic): 402.2056AlogP: 3.28#Rotatable Bonds: 6
Polar Surface Area: 64.62Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.30CX LogP: 3.44CX LogD: 3.18
Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.52Np Likeness Score: -1.12

References

1. Chang Q, Long J, Hu L, Chen Z, Li Q, Hu G..  (2020)  Drug repurposing and rediscovery: Design, synthesis and preliminary biological evaluation of 1-arylamino-3-aryloxypropan-2-ols as anti-melanoma agents.,  28  (9): [PMID:32216987] [10.1016/j.bmc.2020.115404]

Source